-
1
-
-
67349083892
-
Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis
-
Adya R., Tan B.K., Chen J., Randeva H.S. Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis 2009; 205: 113—119.
-
(2009)
Atherosclerosis
, vol.205
, pp. 113-119
-
-
Adya, R.1
Tan, B.K.2
Chen, J.3
Randeva, H.S.4
-
2
-
-
31544441013
-
Low urinary placental growth factor is a marker of pre-eclampsia
-
Aggarwal P.K., Jain V., Sakhuja V. et al. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int 2006; 69: 621—624.
-
(2006)
Kidney Int
, vol.69
, pp. 621-624
-
-
Aggarwal, P.K.1
Jain, V.2
Sakhuja, V.3
-
3
-
-
0036019539
-
Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia
-
Aksoy H., Kumtepe Y., Akcay F., Yildirim A.K. Correlation of P-selectin and lipoprotein(a), and other lipid parameters in preeclampsia. Clin Exp Med 2002; 2: 39—43.
-
(2002)
Clin Exp Med
, vol.2
, pp. 39-43
-
-
Aksoy, H.1
Kumtepe, Y.2
Akcay, F.3
Yildirim, A.K.4
-
4
-
-
36148972797
-
Performance of a panel of maternal serum markers in predicting preeclampsia at 11—15 weeks’ gestation
-
Banzola I., Farina A., Concu M. et al. Performance of a panel of maternal serum markers in predicting preeclampsia at 11—15 weeks’ gestation. Prenat Diagn 2007; 27: 1005—1010.
-
(2007)
Prenat Diagn
, vol.27
, pp. 1005-1010
-
-
Banzola, I.1
Farina, A.2
Concu, M.3
-
5
-
-
0037342076
-
Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction
-
Bretelle F., Sabatier F., Desprez D. et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 2003; 89: 486—492.
-
(2003)
Thromb Haemost
, vol.89
, pp. 486-492
-
-
Bretelle, F.1
Sabatier, F.2
Desprez, D.3
-
6
-
-
3242708015
-
Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies
-
Burger O., Pick E., Zwickel J. et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004; 25: 608—622.
-
(2004)
Placenta
, vol.25
, pp. 608-622
-
-
Burger, O.1
Pick, E.2
Zwickel, J.3
-
7
-
-
33646076702
-
Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction
-
Cetin I., Cozzi V., Pasqualini F. et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynec 2006; 194: 1347—1353.
-
(2006)
Am J Obstet Gynec
, vol.194
, pp. 1347-1353
-
-
Cetin, I.1
Cozzi, V.2
Pasqualini, F.3
-
8
-
-
3442884269
-
Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award
-
Chaiworapongsa T., Romero R., Espinoza J. et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynec 2004; 190: 1541—1547.
-
(2004)
Am J Obstet Gynec
, vol.190
, pp. 1541-1547
-
-
Chaiworapongsa, T.1
Romero, R.2
Espinoza, J.3
-
9
-
-
20244362656
-
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
-
Chaiworapongsa T., Romero R., Kim Y.M. et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3—18.
-
(2005)
J Matern Fetal Neonatal Med
, vol.17
, pp. 3-18
-
-
Chaiworapongsa, T.1
Romero, R.2
Kim, Y.M.3
-
10
-
-
37849018744
-
Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
-
Chaiworapongsa T., Romero R., Gotsch F. et al. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age. J Matern Fetal Neonatal Med 2008; 21: 41—52.
-
(2008)
J Matern Fetal Neonatal Med
, vol.21
, pp. 41-52
-
-
Chaiworapongsa, T.1
Romero, R.2
Gotsch, F.3
-
12
-
-
41049110633
-
Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia
-
Chavarria M.E., Lara-Gonzalez L., Garcia-Paleta Y. et al. Adhesion molecules changes at 20 gestation weeks in pregnancies complicated by preeclampsia. Eur J Obstet Gynecol Reprod Biol 2008; 137: 157—164.
-
(2008)
Eur J Obstet Gynecol Reprod Biol
, vol.137
, pp. 157-164
-
-
Chavarria, M.E.1
Lara-Gonzalez, L.2
Garcia-Paleta, Y.3
-
13
-
-
33947394077
-
First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system
-
Cowans N.J., Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007; 27: 264—271.
-
(2007)
Prenat Diagn
, vol.27
, pp. 264-271
-
-
Cowans, N.J.1
Spencer, K.2
-
14
-
-
33845956065
-
Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia
-
Diesch C.H., Holzgreve W., Hahn S., Zhong X.Y. Comparison of activin A and cell-free fetal DNA levels in maternal plasma from patients at high risk for preeclampsia. Prenat Diagn 2006; 26: 1267—1270.
-
(2006)
Prenat Diagn
, vol.26
, pp. 1267-1270
-
-
Diesch, C.H.1
Holzgreve, W.2
Hahn, S.3
Zhong, X.Y.4
-
15
-
-
13444267698
-
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
-
Dragun D., Muller D.N., Brasen J.H. et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558—569.
-
(2005)
N Engl J Med
, vol.352
, pp. 558-569
-
-
Dragun, D.1
Muller, D.N.2
Brasen, J.H.3
-
16
-
-
7044251939
-
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)
-
Dugoff L., Hobbins J.C., Malone F.D. et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial) Am J Obstet Gynec 2004; 191: 1446—1451.
-
(2004)
Am J Obstet Gynec
, vol.191
, pp. 1446-1451
-
-
Dugoff, L.1
Hobbins, J.C.2
Malone, F.D.3
-
17
-
-
43249093630
-
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-forgestational age
-
Erez O., Romero R., Espinoza J. et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-forgestational age. J Matern Fetal Neonatal Med 2008; 21: 279—287.
-
(2008)
J Matern Fetal Neonatal Med
, vol.21
, pp. 279-287
-
-
Erez, O.1
Romero, R.2
Espinoza, J.3
-
18
-
-
33846900883
-
Defferential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function
-
Fasshauer M., Bluher M., Stumvoll M. et al. Defferential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function. Clin Endocrinol (Oxf) 2007; 66: 434—439.
-
(2007)
Clin Endocrinol (Oxf)
, vol.66
, pp. 434-439
-
-
Fasshauer, M.1
Bluher, M.2
Stumvoll, M.3
-
19
-
-
19944433652
-
Visfatin: a protein secreted by visceral fat that mimics the effects of insulin
-
Fukuhara A., Matsuda M., Nishizawa M. et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426—430.
-
(2005)
Science
, vol.307
, pp. 426-430
-
-
Fukuhara, A.1
Matsuda, M.2
Nishizawa, M.3
-
20
-
-
0347993133
-
Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies
-
Gratton R.J., Gluszynski M., Mazzuca D.M. et al. Adrenomedullin messenger ribonucleic acid expression in the placentae of normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2003; 88: 6048—6055.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 6048-6055
-
-
Gratton, R.J.1
Gluszynski, M.2
Mazzuca, D.M.3
-
21
-
-
43449134064
-
AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia
-
Herse F., Staff A.C., Hering L. et al. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J Mol Med 2008; 86: 697—703.
-
(2008)
J Mol Med
, vol.86
, pp. 697-703
-
-
Herse, F.1
Staff, A.C.2
Hering, L.3
-
22
-
-
59849123575
-
Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study
-
Herse F., Verlohren S., Wenzel K. et al. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009; 53: 393—398.
-
(2009)
Hypertension
, vol.53
, pp. 393-398
-
-
Herse, F.1
Verlohren, S.2
Wenzel, K.3
-
23
-
-
2342417817
-
Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women
-
Holthe M.R., Staff A.C., Berge L.N., Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynec 2004; 190: 1128—1134.
-
(2004)
Am J Obstet Gynec
, vol.190
, pp. 1128-1134
-
-
Holthe, M.R.1
Staff, A.C.2
Berge, L.N.3
Lyberg, T.4
-
24
-
-
41649118423
-
Serum visfatin levels in late pregnancy and pre-eclampsia
-
Hu W., Wang Z., Wang H. et al. Serum visfatin levels in late pregnancy and pre-eclampsia. Acta Obstet Gynec Scand 2008; 87: 413—418.
-
(2008)
Acta Obstet Gynec Scand
, vol.87
, pp. 413-418
-
-
Hu, W.1
Wang, Z.2
Wang, H.3
-
25
-
-
50049108374
-
Longitudinal determination of serum placental protein 13 during development of preeclampsia
-
Huppertz B., Sammar M., Chefetz I. et al. Longitudinal determination of serum placental protein 13 during development of preeclampsia. Fetal Diagn Ther 2008; 24: 230—236.
-
(2008)
Fetal Diagn Ther
, vol.24
, pp. 230-236
-
-
Huppertz, B.1
Sammar, M.2
Chefetz, I.3
-
26
-
-
43849113456
-
Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia
-
Jeyabalan A., McGonigal S., Gilmour C. et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta 2008; 29: 555—563.
-
(2008)
Placenta
, vol.29
, pp. 555-563
-
-
Jeyabalan, A.1
McGonigal, S.2
Gilmour, C.3
-
27
-
-
67749147528
-
First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk
-
Khalil A., Cowans N.J., Spencer K. et al. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk. Prenat Diagn 2009; 8: 781—789.
-
(2009)
Prenat Diagn
, vol.8
, pp. 781-789
-
-
Khalil, A.1
Cowans, N.J.2
Spencer, K.3
-
28
-
-
0027197671
-
Adrenomedulli: a novel hypotensive peptide isolated from human pheochromocytoma
-
Kitamura K., Kangawa K., Kawamoto M. et al. Adrenomedulli: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553—560.
-
(1993)
Biochem Biophys Res Commun
, vol.192
, pp. 553-560
-
-
Kitamura, K.1
Kangawa, K.2
Kawamoto, M.3
-
29
-
-
7044261025
-
Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes
-
Krantz D., Goetzl L., Simpson J.L. et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynec 2004; 191: 1452—1458.
-
(2004)
Am J Obstet Gynec
, vol.191
, pp. 1452-1458
-
-
Krantz, D.1
Goetzl, L.2
Simpson, J.L.3
-
30
-
-
21244479342
-
Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia
-
Laigaard J., Sorensen T., Placing S. et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynec 2005; 106: 144—149.
-
(2005)
Obstet Gynec
, vol.106
, pp. 144-149
-
-
Laigaard, J.1
Sorensen, T.2
Placing, S.3
-
31
-
-
18044370643
-
Circulating angiogenic factors in preeclampsia
-
Levine R.J., Karumanchi S.A. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynec 2005; 48: 372—386.
-
(2005)
Clin Obstet Gynec
, vol.48
, pp. 372-386
-
-
Levine, R.J.1
Karumanchi, S.A.2
-
32
-
-
10744227199
-
Circulating angiogenic factors and the risk of preeclampsia
-
Levine R.J., Maynard S.E., Qian C. et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672—683.
-
(2004)
N Engl J Med
, vol.350
, pp. 672-683
-
-
Levine, R.J.1
Maynard, S.E.2
Qian, C.3
-
33
-
-
1642423713
-
Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia
-
Levine R.J., Qian C., LeShane E.S. et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynec 2004; 190: 707—713.
-
(2004)
Am J Obstet Gynec
, vol.190
, pp. 707-713
-
-
Levine, R.J.1
Qian, C.2
LeShane, E.S.3
-
34
-
-
19944426139
-
Urinary placental growth factor and risk of preeclampsia
-
Levine R.J., Thadhani R., Qian C. et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005; 293: 77—85.
-
(2005)
JAMA
, vol.293
, pp. 77-85
-
-
Levine, R.J.1
Thadhani, R.2
Qian, C.3
-
35
-
-
0342618532
-
Presence of fetal DNA in maternal plasma and serum
-
Lo Y.M., Corbetta N., Chamberlain P.F. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485—487.
-
(1997)
Lancet
, vol.350
, pp. 485-487
-
-
Lo, Y.M.1
Corbetta, N.2
Chamberlain, P.F.3
-
36
-
-
33847013371
-
Microparticle-associated P-selectin reflects platelet activation in preeclampsia
-
Lok C.A., Nieuwland R., Sturk A. et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 2007; 18: 68—72.
-
(2007)
Platelets
, vol.18
, pp. 68-72
-
-
Lok, C.A.1
Nieuwland, R.2
Sturk, A.3
-
37
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
-
Maynard S.E., Min J.Y., Merchan J. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649—658.
-
(2003)
J Clin Invest
, vol.111
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.Y.2
Merchan, J.3
-
38
-
-
34548446787
-
Angiogenic factors for the prediction of preeclampsia in high-risk women
-
Moore Simas T.A., Crawford S.L. et al. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynec 2007; 197: 244—248.
-
(2007)
Am J Obstet Gynec
, vol.197
, pp. 244-248
-
-
Moore Simas, T.A.1
Crawford, S.L.2
-
39
-
-
33846527541
-
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
-
Moschen A.R., Kaser A., Enrich B. et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunology 2007; 178: 1748—1758.
-
(2007)
J Immunology
, vol.178
, pp. 1748-1758
-
-
Moschen, A.R.1
Kaser, A.2
Enrich, B.3
-
40
-
-
31144463307
-
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound
-
Nicolaides K.H., Bindra R., Turan O.M. et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynec 2006; 27: 13—17.
-
(2006)
Ultrasound Obstet Gynec
, vol.27
, pp. 13-17
-
-
Nicolaides, K.H.1
Bindra, R.2
Turan, O.M.3
-
41
-
-
58149292244
-
First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome
-
Poon L.C., Chelemen T., Granvillano O. et al. First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome. Obstet Gynec 2008; 112: 1082— 1090.
-
(2008)
Obstet Gynec
, vol.112
, pp. 1082-1090
-
-
Poon, L.C.1
Chelemen, T.2
Granvillano, O.3
-
42
-
-
34250858133
-
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing pr eeclampsia
-
Rana S., Karumanchi S.A., Levine R.J. et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing pr eeclampsia. Hypertension 2007; 50: 137—142.
-
(2007)
Hypertension
, vol.50
, pp. 137-142
-
-
Rana, S.1
Karumanchi, S.A.2
Levine, R.J.3
-
43
-
-
60249089098
-
The two stage model of preeclampsia: variations on the theme
-
Roberts J.M., Hubel C.A. The two stage model of preeclampsia: variations on the theme. Placenta 2009; 30: 32—37.
-
(2009)
Placenta
, vol.30
, pp. 32-37
-
-
Roberts, J.M.1
Hubel, C.A.2
-
44
-
-
33745274791
-
Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia
-
Robinson C.J., Johnson D.D., Chang E.Y. et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynec 2006; 195: 255—259.
-
(2006)
Am J Obstet Gynec
, vol.195
, pp. 255-259
-
-
Robinson, C.J.1
Johnson, D.D.2
Chang, E.Y.3
-
45
-
-
34547578314
-
Soluble endoglin as a second-trimester marker for preeclampsia
-
Robinson C.J., Johnson D.D. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynec 2007; 197: 174— 175.
-
(2007)
Am J Obstet Gynec
, vol.197
, pp. 174-175
-
-
Robinson, C.J.1
Johnson, D.D.2
-
46
-
-
48149087254
-
First-trimester maternal serum PP13 in the risk assessment for preeclampsia
-
Romero R., Kusanovic J.P., Than N.G. et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynec 2008; 199: 122.
-
(2008)
Am J Obstet Gynec
, vol.199
, pp. 122
-
-
Romero, R.1
Kusanovic, J.P.2
Than, N.G.3
-
47
-
-
37849021866
-
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
-
Romero R., Nien J.K., Espinoza J. et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9—23.
-
(2008)
J Matern Fetal Neonatal Med
, vol.21
, pp. 9-23
-
-
Romero, R.1
Nien, J.K.2
Espinoza, J.3
-
48
-
-
33746890890
-
Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia
-
Rovere-Querini P., Antonacci S., Dell’Antonio G. et al. Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia. Obstet Gynec 2006; 108: 148—155.
-
(2006)
Obstet Gynec
, vol.108
, pp. 148-155
-
-
Rovere-Querini, P.1
Antonacci, S.2
Dell’Antonio, G.3
-
49
-
-
34347249118
-
Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy
-
Salahuddin S., Lee Y., Vadnais M. et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynec 2007; 197: 28—36.
-
(2007)
Am J Obstet Gynec
, vol.197
, pp. 28-36
-
-
Salahuddin, S.1
Lee, Y.2
Vadnais, M.3
-
50
-
-
41549112891
-
Study of plasma adrenomedullin level in normal pregnancy and preclampsia
-
Senna A.A., Zedan M., Salam G.E., Mashad A.I. Study of plasma adrenomedullin level in normal pregnancy and preclampsia. Medscape J Med 2008; 10: 29.
-
(2008)
Medscape J Med
, vol.10
, pp. 29
-
-
Senna, A.A.1
Zedan, M.2
Salam, G.E.3
Mashad, A.I.4
-
51
-
-
67650327064
-
Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
-
Sheng Wen Liu, Shu Bin Qiao, Jian Song Yuan, Dong Qin Liu. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol 2009; 71: 2: 202—207.
-
(2009)
Clin Endocrinol
, vol.71
, Issue.2
, pp. 202-207
-
-
Liu, Sheng Wen1
Qiao, Shu Bin2
Yuan, Jian Song3
Liu, Dong Qin4
-
53
-
-
41149086146
-
ADAM12s in maternal serum as a potential marker of pre-eclampsia
-
Spencer K., Cowans N.J., Stamatopoulou A. ADAM12s in maternal serum as a potential marker of pre-eclampsia. Prenat Diagn 2008; 28: 212—216.
-
(2008)
Prenat Diagn
, vol.28
, pp. 212-216
-
-
Spencer, K.1
Cowans, N.J.2
Stamatopoulou, A.3
-
54
-
-
33847277304
-
First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia
-
Spencer K., Cowans N.J., Chefetz I. et al. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of preeclampsia. Ultrasound Obstet Gynec 2007; 29: 128—134.
-
(2007)
Ultrasound Obstet Gynec
, vol.29
, pp. 128-134
-
-
Spencer, K.1
Cowans, N.J.2
Chefetz, I.3
-
55
-
-
33947388873
-
Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of preeclampsia
-
Spencer K., Cowans N.J., Chefetz I. et al. Second-trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of preeclampsia. Prenat Diagn 2007; 27: 258—263.
-
(2007)
Prenat Diagn
, vol.27
, pp. 258-263
-
-
Spencer, K.1
Cowans, N.J.2
Chefetz, I.3
-
56
-
-
39149131084
-
Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia
-
Spencer K., Cowans N.J., Nicolaides K.H. Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia. Prenat Diagn 2008; 28: 7—10.
-
(2008)
Prenat Diagn
, vol.28
, pp. 7-10
-
-
Spencer, K.1
Cowans, N.J.2
Nicolaides, K.H.3
-
57
-
-
43249123064
-
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery
-
Spencer K., Cowans N.J., Molina F. et al. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Ultrasound Obstet Gynec 2008; 31: 147—152.
-
(2008)
Ultrasound Obstet Gynec
, vol.31
, pp. 147-152
-
-
Spencer, K.1
Cowans, N.J.2
Molina, F.3
-
58
-
-
34447125104
-
Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
-
Stepan H., Kramer T., Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2007; 92: 2831—2834.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2831-2834
-
-
Stepan, H.1
Kramer, T.2
Faber, R.3
-
59
-
-
34047232484
-
Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion
-
Stepan H., Unversucht A., Wessel N., Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818—824.
-
(2007)
Hypertension
, vol.49
, pp. 818-824
-
-
Stepan, H.1
Unversucht, A.2
Wessel, N.3
Faber, R.4
-
60
-
-
38349087878
-
Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion
-
Stepan H., Geipel A., Schwarz F. et al. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynec 2008; 198: 175—176.
-
(2008)
Am J Obstet Gynec
, vol.198
, pp. 175-176
-
-
Stepan, H.1
Geipel, A.2
Schwarz, F.3
-
61
-
-
1442303327
-
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia
-
Thadhani R., Mutter W.P., Wolf M. et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770—775.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 770-775
-
-
Thadhani, R.1
Mutter, W.P.2
Wolf, M.3
-
62
-
-
10744232684
-
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences
-
Tsatsaris V., Goffin F., Munaut C. et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003; 88: 5555—5563.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5555-5563
-
-
Tsatsaris, V.1
Goffin, F.2
Munaut, C.3
-
63
-
-
33744985816
-
Soluble endoglin contributes to the pathogenesis of preeclampsia
-
Venkatesha S., Toporsian M., Lam C. et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642—649.
-
(2006)
Nat Med
, vol.12
, pp. 642-649
-
-
Venkatesha, S.1
Toporsian, M.2
Lam, C.3
-
64
-
-
31944451457
-
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature
-
Walther T., Wallukat G., Jank A. et al. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005; 46: 1275—1279.
-
(2005)
Hypertension
, vol.46
, pp. 1275-1279
-
-
Walther, T.1
Wallukat, G.2
Jank, A.3
-
65
-
-
30344453927
-
Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation
-
Wathen K.A., Tuutti E., Stenman U.H. et al. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 2006; 91: 180—184.
-
(2006)
J Clin Endocrinol Metab
, vol.91
, pp. 180-184
-
-
Wathen, K.A.1
Tuutti, E.2
Stenman, U.H.3
-
66
-
-
34249908643
-
Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
-
Wikstrom A.K., Larsson A., Eriksson U.J. et al. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynec 2007; 109: 1368—1374.
-
(2007)
Obstet Gynec
, vol.109
, pp. 1368-1374
-
-
Wikstrom, A.K.1
Larsson, A.2
Eriksson, U.J.3
-
67
-
-
40849105128
-
Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling
-
Zhou C.C., Ahmad S., Mi T. et al. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008; 51: 1010—1019.
-
(2008)
Hypertension
, vol.51
, pp. 1010-1019
-
-
Zhou, C.C.1
Ahmad, S.2
Mi, T.3
|